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Abstract Creatine kinases (CK) play a prominent role in cell
energy distribution through an energy shuttle between mitochon-
dria and other organelles. Human brain CK was cloned and
overexpressed in COS-7 cells. We then deleted His-65 and/or
Pro-66 situated near the center of a flexible loop as shown by
X-ray crystallography on mitochondrial and cytosolic CK. The
vH65 mutant had nearly the same affinity for its substrates as
wild isoenzyme, but its stability was very low. Unlike vH65,
vH65P66 had a eightfold decreased affinity for creatine
phosphate and was unable to dephosphorylate cyclocreatine
phosphate. Our results demonstrate that, despite an overall
similar shape of the proteins, this loop accounts for some subtle
differences in isoenzyme functions. ß 2000 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Creatine kinases (ATP:creatine phosphotransferase, EC
2.7.3.2; CK) are key enzymes in the regulation of cellular
energy homeostasis. They are the two ends of a cell energy
shuttle between mitochondria and cellular substructures. The
mitochondrial isoform of CK, CK-Mi, which is bound to the
outer surface of the inner mitochondrial membrane, phos-
phorylates creatine with ATP to export energy as creatine
phosphate (CP) from the mitochondria. Then ADP is
phosphorylated in the presence of CP by cytosolic CK isoen-
zymes which are associated with subcellular structures requir-
ing ATP, e.g. microtubules, membrane structure of sarcoplas-
mic reticulum and myo¢brils [1^5].
Two di¡erent genes encode two cytosolic CK subunits: B
(brain) and M (muscle), with a molecular mass of V41 kDa
and a high amino acid sequence homology (78^80%) among
species [6]. The subunits associate to form homodimeric (MM,
BB) and heterodimeric (MB) isoenzymes. The MM and MB
forms are characteristic of skeletal and heart muscle whereas
the BB form is predominant in brain. There are also two
mitochondrial forms: ubiquitous (CK-Mia) and sarcomeric
(CK-Mib) mitochondrial CK [3,5,7], encoded by two di¡erent
genes [8]. Each mitochondrial subunit has a molecular weight
of approximately 42 kDa and the active forms are dimeric and
octameric. Recently, chicken muscle CK-Mib was crystallized
without its substrates and its X-ray structure analyzed [9].
More recently, the same group published the crystal structure
at 1.41 Aî resolution [10].
The function of some amino acid residues has been inves-
tigated by site-directed mutagenesis. Since it had been sug-
gested that a histidine residue may act as a general acid^
base catalyst [11,12], the Kenyon group tried to identify this
residue by mutagenesis of conserved His-96, His-105, His-190,
His-223 and His-295, in rabbit muscle CK. Neither of these
amino acids was essential for catalysis [13].
In mitochondrial isoenzymes, a reactive cysteine, Cys-278,
conserved among the guanidine kinases has been shown to
play an important role in the synergism of substrate binding,
but not to be essential for catalysis [14].
The mutation of six Trp residues of chicken sarcomeric
mitochondrial CK by site-directed mutagenesis identi¢ed
Trp-223 as an active site residue and Trp-206 as important
for conformation and active site stabilization [15]. In a similar
manner, Trp-210 was shown to be essential for stabilizing the
dimeric active state of CK-MM [16]. According to the X-ray
crystallographic structure, three of the ¢ve conserved histi-
dines surrounding the active site (His-61, 92, and 186 of chick-
en CK-Mib) were mutated [17]. The ¢rst, corresponding to
His-65 in CK-BB, seemed to be important for the catalytic
reaction but did not serve as an acid^base catalyst in the
transphosphorylation reaction. Forstner et al. [17] suggested
the involvement of His-92 and His-186 in the binding of crea-
tine and ATP in the active site. They also suggested the role of
a £exible loop bearing this His-61, highly conserved through
all of the CKs. This loop moves towards the guanidine sub-
strate binding site and contributes to catalysis. In our labo-
ratory, we worked on synthesizing selective and speci¢c inhib-
itors of CK isoenzymes [18]. Further data indicated noticeable
di¡erences between inhibition of cytosolic isoenzymes and dif-
ferent catalytic mechanisms [19]. These results strongly sug-
gested some di¡erences in the creatine binding domain of the
human CK-BB and CK-MM. These data emphasize that CK
isoenzyme speci¢city relies more on the CP than on the nu-
cleotide binding domain. In order to determine the CP bind-
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ing domain in CK-MM, we synthesized a photoactivatable
bisubstrate analog, BzPG (N-dibenzylphospho-NP-(4-benzo-
yl)-benzylguanidine) [20]. After photoa⁄nity labeling and
CNBr cleavage of rabbit CK-MM, this photoprobe allowed
us to sequence a peptide Ala-30^Val-60 belonging to the CP
binding site [20]. We therefore decided to use site-directed
mutagenesis to focus on the potential role of His-65 in CK-
BB in comparison to CK-Mi. We performed a deletion of His-
65 and/or Pro-66 on a histidine-tagged human isoenzyme. As
mutants were expressed in COS-7 cells containing their own
CK-BB, the tag avoided any contamination by endogenous
CK.
Despite the similar shape of these two isoenzymes revealed
by crystallography, we show that the £exible loop plays a
di¡erent role in CK-BB. Our results also suggest that nucle-
otidic and CP binding sites interact di¡erently.
2. Materials and methods
2.1. Materials
The following items were obtained from the indicated sources:
ADP, NAD, NADH, hexokinase (EC 2.7.1.1), glucose-6-phosphate
dehydrogenase (EC 1.1.1.49), pBH vector (ref. 1814605) (Roche Mo-
lecular Biochemicals); cellular RNA was extracted with RNeasy Mini
kit (Qiagen, ref. 74106), Qiagen Plasmid Maxi kit (Qiagen, refs. 74106
and 12263); human brain mRNA (Clontech, ref. 6543-1); Escherichia
coli strain DH5K competent cells, Dulbecco’s modi¢ed Eagle’s me-
dium (DMEM) (Gibco BRL, refs. 18265-017 and 32430-027 respec-
tively), expression vector pcDNA3.1(+), pZeoSV40 (Invitrogen, refs.
V790-20 and V850-01 respectively), CK isoenzyme electrophoresis kit
(Beckman, ref. 655930), Enzyline CK standardized 10 (Biomerieux,
ref. 63151).
2.2. BCK cDNA and construction of expression vectors
The single-stranded cDNA of the BCK gene was synthesized from
human brain mRNA using the ¢rst-strand cDNA synthesis kit (Phar-
macia, ref. 27-9261-01). The BCK cDNA was ampli¢ed by PCR using
two primers containing a HindIII restriction site (forward: 5P-CGG
CCC AAG CTT GCC ATG CCC TTC TCC AAC AG-3P and re-
verse: 5P-GGG TGT AAG CTT GGC TTC ATT TCT GGG CAG
GC-3P, accession: M16451, nt 21^40 and nt 1173^1153 respectively of
the cDNA sequence) and Pfu polymerase (Stratagene, ref. 600153).
These PCR products of 1153 bp were inserted into the HindIII site of
a Bluescript II KS vector (Stratagene, ref. 212205). Clones were se-
quenced by the dideoxynucleotide technique using Thermo Sequenase
(Amersham Pharmacia Biotech, ref. US7950). The correct BCK
cDNA was subcloned into two eukaryotic expression vectors,
pZeoSV40 and pcDNA3.1, to obtain pZe-BCK and pcD-BCK respec-
tively.
2.3. Histidine tag addition to the 3P-terminus of the BCK cDNA
In order to construct a novel BCK including a six histidine tag
sequence on the 3P-terminus, we performed a PCR by changing the
reverse primer (5P-ACG AGA AGC TTT CAA TGA TGA TGA
TGA TGA TGC TTA TCG TCG TCG TCT TTC TGG GCA
GGC ATG AGG TCG TC-3P). The reverse primer contains the Hin-
dIII restriction site, an enterokinase cleavage site and a sequence
encoding 6His. This newly synthesized B6H-CK cDNA of 1191 bp
was inserted into the HindIII site of a pcDNA3.1 vector. The DNA
sequence of PCR products was veri¢ed. The pcD-BCK6His clone was
selected for expression study.
2.4. Site-directed mutagenesis of BCK
The deletion of His-65 and Pro-66 and the double deletion His-65^
Pro-66 was performed by the megaprimer method [21] on the B6H-
CK cDNA. We used a modi¢cation of the megaprimer technique
proposed by Ekici et al. [22]. This in vitro mutagenesis is based on
a one tube, two stage PCR reaction using a set of three primers and
Tfu polymerase (Appligene, ref. 120241). For the ¢rst two single ami-
no acid deletions, in the ¢rst step, the 3P universal BGH reverse prim-
er (5P-TAG AAG GCA CAG TCG AGG-3P) and the 5P mutagenic
primer (Table 1) generate and amplify a double-stranded, mutated
fragment of 1140 bp for 16 cycles. Each cycle consisted of 45 s of
denaturation at 95‡C, 45 s at 60‡C and 90 s at 72‡C. This synthesized
fragment carrying the mutation is used as a megaprimer together with
the 5P universal T7 primer in the second step PCR reaction, using the
same cycling conditions to obtain the desired 1.2 kb mutated frag-
ment.
For the double deletion His-65^Pro-66, the 3P primer in the ¢rst
step and the 5P primer of the second step of the megaprimer reaction,
we used the NheI-pcDNA primer (5P-AAGCTGGCTAGCGTT-
TAAACTTAA-3P, nt 889^912 of pcDNA3.1 vector) and the Bam-
HI-pcDNA primer (5P-AGTGGATCCGAGCTCGGTACC-3P, nt
916^937 of pcDNA3.1 vector) which generated a fragment of approx-
imately 1.2 kb. The mutated fragment was then puri¢ed on agarose
0.8% and reintroduced into the pcDNA3.1 vector. The deletion was
con¢rmed by sequencing with the USB Sequenase kit (Amersham
Pharmacia Biotech, ref. US78500).
2.5. Cell culture and transfection
COS-7 cells were cultured in a DMEM^25 mM HEPES medium
supplemented with 12% (v/v) fetal calf serum under 5% CO2 at 37‡C.
Plasmid was introduced in COS cells with 0.3% (v/v) FuGENE-6
transfectant reagent (Roche Molecular Biochemicals, ref. 1814443)
and expressed for 48 h. Each transfection experiment was repeated
three times.
2.6. Extraction of the recombinant protein CK-BB
After 48 h, cells were harvested by trypsinization in TE and cen-
trifugation at 1500 rpm at 4‡C for 5 min. Cells were washed three
times with phosphate-bu¡ered saline and frozen at 380‡C until as-
sayed. The pellets were resuspended on ice in a lysis bu¡er (100 mM
Tris^HCl, 200 mM NaCl, pH 7.0). Three cycles of freezing-thawing
were carried out, and insoluble cell debris was removed by centrifu-
gation at 12 000 rpm at 4‡C for 6 min. The extracts were used for CK
catalytic and gel analysis and for total protein measurement.
2.7. Puri¢cation of CK-BB6His
The His-tagged CK-BB protein (CK-BB(His)6) expressed in COS
was puri¢ed on a nickel a⁄nity column (Ni-NTA super£ow, Qiagen,
ref. 30410) under native conditions. After washing with 100 mM imi-
dazole, CK-BB(His)6 was eluted with 250 mM imidazole, 1 M NaCl,
50 mM phosphate bu¡er (pH 8.0). The fractions containing CK ac-
tivity were pooled and dialyzed against a bu¡er (100 mM Tris^HCl,
50 mM NaCl, 6 mM dithiothreitol (DTT), pH 8.0). The puri¢ed
enzyme was stored at 320‡C after the addition of 4 g/l bovine serum
albumin and 50% glycerol.
2.8. Mi-CK cDNA and construction of expression vectors
Total RNA was prepared from MCF-7 cells. The single-stranded
cDNA was synthesized with the Omniscript RT kit (Qiagen, ref.
205111) using oligo-dT as a primer. The Mi-CK cDNA was ampli¢ed
for 20 cycles, each consisting of 30 s at 94‡C for denaturation, 1 min
at 45‡C for annealing and 2 min at 72‡C for primer extension by the
polymerase. The primers used were CK-Mi for (5P-GTA CGA AAG
CTT AGC TGC CAG TGA ACG ACG G-3P) and CK-Mi rev (5P-
GGG GAG GAA TTC TTA ATG CTT GGT GTG GAT-3P). These
primers contain the HindIII and EcoRI restriction sites and are posi-
tioned on nt 518^535 and nt 5582^5570, respectively, of the genomic
sequence (accession number J04469). The 1.2 kb products were puri-
¢ed with the Qiaquick PCR puri¢cation kit, subcloned into pBlue-
script II KS vector, followed by transformation into E. coli DH5K
competent cells. Clones obtained were sequenced (ESGS/Genopole,
Table 1




His-65 GTG GAC AAC CCG GGC T CCG TAC ATC ATG
ACC
His-65^Pro-66 GTG GAC AAC CCG GGC T TAC ATC ATG ACC
GTG
CK-MivHis61 GTG GAC AAC CCT GGC T CCC TTC ATC AAG
ACT
The deletion of amino acids is represented by three dots.
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Evry, France). The correct Mi-CK cDNA was subcloned into the
prokaryotic expression vector pBH, to obtain pBH-MiCK.
2.9. Deletion of His-61 by site-directed mutagenesis of human Mi-CK
The deletion was performed on Mi-CK cDNA as described previ-
ously by the megaprimer method. The three primers used were CK-Mi
for, CK-Mi rev and the mutagenic oligonucleotide CK-MivHis61
(Table 1). The two PCR reactions were performed for 16 cycles
each consisting of 45 s at 94‡C, 45 s at 46‡C for the ¢rst PCR reac-
tion, 55‡C for the second one and 1 min at 72‡C for the extension.
The resulting 1.2 kb DNA fragment was puri¢ed, cloned in pBH
vector and sequenced as described for the wild-type Mi-CK cDNA.
2.10. CK-Mi protein puri¢cation
E. coli DH5K cells were transformed with plasmids encoding the
mutant or the wild-type enzymes, and proteins were expressed in E.
coli and puri¢ed. The expression of CK-Mi protein was induced by
the addition of 1 mM IPTG. After 5 h induction, cells were pelleted
(10 min, 5000 rpm, 4‡C), washed, centrifuged a second time and
resuspended in 10 ml of an ice-cold extraction bu¡er (Tris^HCl
50 mM, EDTA 10 mM, NaCl 100 mM, pH 8) supplemented with a
protease inhibitor cocktail tablet (complete, Mini, EDTA, Roche Bio-
chemicals, ref. 1836170) and 0.5 mg/ml lysozyme. Cells were incubated
on ice for 15 min, lysed by sonication for 10 s and placed on ice for
2 min. This was repeated three times, followed by three freeze-thaw
cycles and centrifugation for 20 min at 12 000 rpm at 4‡C. The super-
natant was then transferred to be dialyzed against a 25 mM sodium
phosphate, 3 mM DTT, 0.2 mM EDTA, pH 7 bu¡er for 4 h through
a 100 kDa membrane. Finally, we concentrated the protein in a Cen-
triplus-100 concentrator (Amicon). The extracted protein was then
used for CK analysis.
2.11. CK activity measurements
For the reverse reaction (ATP synthesis), CK catalytic activities
were measured with the hexokinase^glucose-6-phosphate dehydrogen-
ase coupled method (Enzyline CK standardized 10, Biomerieux). The
reaction was started by adding CP (30 mM).
2.12. CK isoenzyme analysis by agarose gel electrophoresis
CK isoenzymes in the lysate were analyzed on commercial 1%
agarose gels according to the manufacturer’s instructions. The ¢nal
quanti¢cation was done with an integrator under £uorescent light
(Sebia Preference).
2.13. Protein analysis
Total proteins were measured with the BCA Protein Assay Reagent
(Pierce, ref. 23225). The puri¢ed protein was analyzed by SDS^PAGE
according to the method of Laemmli on a 12% acrylamide gels.
2.14. Km determination
For the reverse reaction, plots were constructed from the activities
measured with CP or cyclocreatine phosphate ranging from 1 to
10 mM, while the ADP concentration was held at 2 mM, and for
ADP (0.1^0.5 mM) with a CP concentration at 30 mM. The Km
values were evaluated by a linear regression method, using a double
reciprocal plot of velocity versus substrate concentration.
2.15. Synthesis of cyclocreatine phosphate
1-Carboxymethyl-2-iminoimidazolidine (cyclocreatine) was chemi-
cally phosphorylated in our laboratory according to the published
procedure [23].
3. Results
3.1. cDNA cloning and overexpression of wild-type CK-BB
After sequencing 20 clones, we chose the clone CKBh2
cDNA for expression study. To avoid the formation of inclu-
sion bodies in E. coli, we decided to produce our protein in a
mammalian cell line, COS-7, previously used by the Perryman
group to express CK [24]. pZe-BCK with SV40 promoter ex-
pressed a low level of recombinant protein, approximately
eightfold that of the endogenous CK-BB in COS-7 cells, while
the pcD-BCK vector with the CMV promoter increased the
expression level up to approximately 200-fold (Table 2). Elec-
trophoretic analysis of native proteins on agarose gel showed
a basal level of BB isoenzyme in non-transfected COS and a
high level of overexpressed CK-BB in transfected cells.
3.2. His-tagged CK-BB
To allow rapid and e⁄cient puri¢cation of the recombinant
protein, we added six histidines and an enterokinase cleavage
site at the C-terminus of CK-BB and obtained pZe-BCK6His
and pcD-BCK6His vectors respectively. The overexpression
level of histidine-tagged CK-BB in COS-7 cells was not af-
fected by the tag and we chose to use pcD-BCK6His for
further experiments (Table 2). The tagged protein was puri¢ed
through a Ni-NTA super£ow column and resulted in one
homogeneous V42 kDa band on the SDS polyacrylamide
gel. Thus the one step puri¢ed enzyme was directly used for
kinetic studies without further puri¢cation.
Km values for CP and ADP of CK-BB(His)6 were 650 and
280 WM respectively and were comparable to the literature
data for CK-BB (660 and 110 WM respectively).
3.3. Deletion of His-65 in human CK-BB6His
We deleted the nucleotides corresponding to His-65 in the
pcD-BCK6His vector by the megaprimer method to obtain
the vHis65 mutant. The mutant protein was expressed in
COS-7 cells, puri¢ed, and characterized.
As shown in Table 3, the Km values of vH65 mutant for CP
and ADP are 710 and 200 WM respectively. The a⁄nity for its
Table 2
Overexpression of recombinant CK-BB enzymes in COS-7 cells




pZeOSV40 0.25 þ 0.01 ^
pcDNA3.1 0.26 þ 0.02 ^
pZe-BCK 2.15 þ 0.02 7.89 þ 0.01
pcD-BCK 50 þ 3.6 200 þ 30
pZe-BCK6His 1.18 þ 0.03 5 þ 1
pcD-BCK6His 44.33 þ 3.74 177 þ 25
Fig. 1. Double reciprocal plots of velocity versus CCrP concentra-
tion for CK-BB(His)6 (triangles) and vHis65 (circles) (n = 3 for each
data point). The error bars are standard deviations, not shown
when smaller than the symbol. CK activities were measured by a
hexokinase^glucose-6-phosphate dehydrogenase coupled method in
the direction of ATP formation. ADP concentration was held at
2 mM.
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two natural substrates is identical to that of CK-BB(His)6.
Further kinetic studies were also performed for CCrP, a
known analog of CP, which has a conformationally restricted
and bulky cyclic structure. The a⁄nity of the vH65 mutant
for CCrP decreased approximately 12-fold in comparison to
that of recombinant 6His (Table 3) or wild-type enzyme (750
WM, personal results) although the maximal velocity of vH65
for CCrP was not greatly changed (Fig. 1).
3.4. Stability of the vHis65 mutant
For stability studies, we checked the catalytic activities over
7 months. CK-BB(His)6 showed no signi¢cant loss of activity
for 5 months and retained a residual activity of approximately
70% after 210 days, whereas vHis65 activity decreased dras-
tically to 10% of its initial activity in a short period, 70 days
(Fig. 2).
3.5. Deletion of Pro-66
Whereas the a⁄nity of this mutant (vP66) for ADP was not
signi¢cantly changed, the Km value for CP was eightfold in
comparison to CK-BB(His)6. It was not possible to determine
the Km value for CCrP since no activity was detected in the
presence of this substrate (Table 3).
3.6. Deletion of His-65^Pro-66
In the cell extract, the double mutant, vH65vP66, exhibited
less than 3% (with CP) of the CK-BB(His)6 activity control. It
exhibited the same a⁄nity for CP and ADP as vP66. The
determination of the Km value for CCrP also failed (Table 3).
3.7. cDNA cloning and expression of wild-type and mutant
CK-Mi (MivH61)
In order to compare our results on His-65 in CK-BB to
those on His-61 in CK-Mi described by Wallimann’s group,
we decided to clone the Mi-CK cDNA. The sequence ob-
tained was 100% homologous to that found by Haas et al.
[25]. After expression in E. coli and puri¢cation, the Michae-
lis^Menten constants for this wild-type enzyme, in the reverse
reaction (Km(CP) = 753 þ 25 WM, Km(ADP) = 145 þ 6 WM),
were in good agreement with those of Forstner et al. [17]
(Km(CP) = 1210 þ 110 WM, Km(ADP) = 166 þ 37 WM). We
then deleted His-61 of the Mi-CK by site-directed mutagene-
sis, and expressed the mutant protein in the same conditions
as the wild-type. No activity could be detected with either of
the natural substrates, CP or ADP (Table 3).
4. Discussion
Several histidine residues conserved throughout the phos-
phagen kinases including CK have been studied either by site-
directed mutagenesis or by chemical modi¢cation. Recently,
Forstner et al. [17] substituted three histidines in the sarco-
meric mitochondrial isoenzyme, CK-Mib, of chicken muscle
(His-61, His-92, and His-186) with Ala and Asp. The most
prominent e¡ects were obtained with the H61D mutant.
According to crystallographic studies, this His (correspond-
ing to His-65 in the cytosolic isoenzymes) is in a £exible loop
[9]. On the one hand, it has been suggested that this loop
moves towards the active site in order to bring His-61 near
the Q-phosphate of ATP. On the other hand, by photoa⁄nity
labeling or computational sequence analysis, the loop was
demonstrated to be at least a part of the CP binding site
[20,26].
To investigate the probable role of this loop in CK-BB
catalysis, we deleted His-65 and Pro-66 successively. The de-
letion of His-65 has no apparent e¡ect on the kinetic param-
eters. This unexpected result prompted us to check our results.
The wild-type CK-Mi enzyme we obtained showed similar
characteristics to that prepared by the Wallimann group. In-
stead of mutating the CK-Mi His-61, we decided to delete it.
The mutant MivH61 is nearly inactive and any trial to char-
acterize this enzyme failed, a result which is in excellent agree-
ment with that for H61D (Table 3). Our results most probably
account for structural di¡erences due to the isoenzyme type.
From the comparison of 18 amino acid sequences of di¡er-
ent phosphagen kinases, Suzuki et al. [26,27] proposed the
His-65^Ile-68 region as a possible candidate for the guanidine
recognition site. They suggested an inverse relationship be-
tween the size of the loop and that of the guanidine substrate.
The deletion of the two amino acids, His-65 and Pro-66, may
alter the loop’s shape and decrease the a⁄nity for relatively
larger substrates such as CCrP. In fact, the deletion of His-65
increased the Km for CCrP about 12-fold without any signi¢-
cant e¡ect on CP binding. Unlike His-65, vP66 showed a
sevenfold decrease in CP a⁄nity, and CCrP a⁄nity was so
low that the catalytic activity was undetectable. vH65vP66
showed the same characteristics as the vP66 mutant, con¢rm-
ing that the deletion of Pro disturbed the loop’s shape, since a
Pro residue often plays an important role in bending a struc-
ture. This explains the weak binding of CP. It seems that, in
the double deletion, Pro-66 is accountable for the Km(CP)
increase. It is noteworthy that, while CP a⁄nity was modi¢ed,
Km(ADP) decreased. This fact has to be related to the ordered
Fig. 2. Stability of CK-BB(His)6 (triangles) and vH65 (circles). CK
activities were measured by a hexokinase^glucose-6-phosphate dehy-
drogenase coupled method in the direction of ATP formation. ADP
and CP concentrations were held at 2 and 30 mM respectively.
Table 3
Kinetic constants for wild-type and mutant CK-BB enzymes in the
direction of ATP formation (mean þ S.D., n = 3)
Km (WM)
CP CCrP ADP
CK-Mi 753 þ 25 ^ 145 þ 6
CK-BB(His)6 650 þ 185 432 þ 24 280 þ 39
vH65 710 þ 43 5340 þ 500 190 þ 12
vP66 4910 þ 118 n.d. 83 þ 6
vH65vP66 4910 þ 240 n.d. 100 þ 7
MivH61 n.d. ^ n.d.
n.d.: not detected.
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catalytic mechanism we previously described at pH 6.6 for
CK-BB [19]. Further experiments are necessary to understand
better how the deletions modulate the interaction between the
two substrate sites.
Although His-65 deletion did not a¡ect in any way the
natural substrates binding to CK-BB, apparently it did have
an e¡ect on the interaction with larger substrates such as
CCrP.
However, an obvious e¡ect of its deletion is a dramatic
decrease in enzyme stability (Fig. 2). While His-65 is not cru-
cial for catalysis in CK-BB, the £exible loop as a whole al-
tered the binding of the guanidine substrate. In this case, the
main role of His-65 may be to stabilize the general conforma-
tion of the protein.
So far, the resolved structures of some members of the
guanidine kinase family have been based on molecular re¢ne-
ment by replacement using the coordinates of CK-Mi (3.0 Aî
resolution) [9] : horseshoe crab ArgK [28], rabbit CK-MM
[29], chicken CK-BB [11]. Perhaps this re¢nement tends to
increase the likeness of the shape of these guanidine kinases.
Moreover, the crystals of CK-BB were obtained in the ab-
sence of any substrate or transition state analog and weak
electron density was reported in the region of the £exible
loop. This leads us to propose that, despite an overall similar
shape, some subtle structural di¡erences exist and contribute
to isoenzyme speci¢cities and functions yet to be clari¢ed.
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